104 related articles for article (PubMed ID: 5342122)
1. Malignant diseases of the blood.
Haurani FI; Thorling KH
Pa Med; 1966 Nov; 69(11):33-6. PubMed ID: 5342122
[No Abstract] [Full Text] [Related]
2. [Current therapy of malignant blood diseases].
de Werra P
Praxis; 1967 Jun; 56(26):901-6. PubMed ID: 5253422
[No Abstract] [Full Text] [Related]
3. [The use of intravenous gamma globulin in malignant hematologic diseases].
Garay GE
Medicina (B Aires); 1989; 49(6):621-7. PubMed ID: 2484842
[No Abstract] [Full Text] [Related]
4. Current trends in chemotherapy of leukaemias lymphomas and multiple myeloma.
Kasili EG
East Afr Med J; 1976 Sep; 53(9):554-9. PubMed ID: 1009883
[No Abstract] [Full Text] [Related]
5. [Application of bis-diketopiperazine in the treatment of acute leukemia and other malignant blood disorders].
Yang QE; Zhang A
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Feb; 6(1):17-20. PubMed ID: 6238688
[No Abstract] [Full Text] [Related]
6. [Cisplatin and carboplatin in the treatment of malignant lymphoma and multiple myeloma].
Adam Z; Mayer J; Hájek R
Vnitr Lek; 1994 Dec; 40(12):790-800. PubMed ID: 7839634
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance to DNA topoisomerase I and II inhibitors in human leukemia, lymphoma, and multiple myeloma.
Valkov NI; Sullivan DM
Semin Hematol; 1997 Oct; 34(4 Suppl 5):48-62. PubMed ID: 9408961
[TBL] [Abstract][Full Text] [Related]
8. [Androgens in hematology].
Sanchez-Medal L
Minerva Med; 1971 Jun; 62(51):2598-604. PubMed ID: 5566873
[No Abstract] [Full Text] [Related]
9. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1997; 17():390-407. PubMed ID: 9551222
[No Abstract] [Full Text] [Related]
10. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1999; 18():268-92. PubMed ID: 10800488
[No Abstract] [Full Text] [Related]
11. [High dose chemotherapy with autologous stem cell transplantation].
Weissinger F; Reimer P; Wilhelm M
Fortschr Med; 1997 Mar; 115(9):39-43. PubMed ID: 9206695
[TBL] [Abstract][Full Text] [Related]
12. [Home care of hematological malignancies].
Urabe A
Gan To Kagaku Ryoho; 2006 May; 33(5):599-601. PubMed ID: 16685155
[TBL] [Abstract][Full Text] [Related]
13. The use of drugs in various types of cancer. II.
Fischer DS
Conn Med; 1971 Mar; 35(3):202-7. PubMed ID: 5581533
[No Abstract] [Full Text] [Related]
14. High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma.
Rugo HS; Damon LE; Ries CA; Wolf JL; Linker CA
Prog Clin Biol Res; 1994; 389():505-11. PubMed ID: 7535460
[No Abstract] [Full Text] [Related]
15. The internist's role in the management of cancer.
Li MC; Kanwal G
Mod Treat; 1971 Nov; 8(4):914-43. PubMed ID: 4334186
[No Abstract] [Full Text] [Related]
16. Second malignancies and chemotherapeutic agents.
Kyle RA
Prog Clin Biol Res; 1983; 132E():45-54. PubMed ID: 6417671
[No Abstract] [Full Text] [Related]
17. Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
Baron F; Gothot A; Salmon JP; Hermanne JP; Pierard GE; Fillet G; Beguin Y
Br J Haematol; 2000 Dec; 111(3):745-53. PubMed ID: 11122133
[TBL] [Abstract][Full Text] [Related]
18. [Current status of chemotherapy of malignant diseases of the hematopoietic organs].
Ducach G
Rev Med Chil; 1970 May; 98(5):309-21. PubMed ID: 5478171
[No Abstract] [Full Text] [Related]
19. Clinical trials referral resource. Clinical trials with arsenic trioxide.
Murgo AJ; McBee WL; Cheson BD
Oncology (Williston Park); 2000 Feb; 14(2):206, 211, 215-6 passim. PubMed ID: 10736809
[No Abstract] [Full Text] [Related]
20. [Standard chemotherapy of hematological cancers].
Mitsuma A; Naoe T
Nihon Naika Gakkai Zasshi; 2009 Aug; 98(8):1880-6. PubMed ID: 19894349
[No Abstract] [Full Text] [Related]
[Next] [New Search]
